# CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases

> **NCT07247396** · PHASE1 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 12 (estimated)

## Conditions studied

- Peritoneal Metastases From Colorectal Cancer

## Interventions

- **BIOLOGICAL:** CEA-targeted CAR-T cells

## Key facts

- **NCT ID:** NCT07247396
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-03
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07247396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07247396, "CEA CAR-T Therapy After Cytoreduction in Colorectal Cancer Patients With Peritoneal Metastases". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07247396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*